Skip to main content

Table 1 Baseline characteristics of the study population

From: Long term prognostic implication of newly detected abnormal glucose tolerance among patients with stable cardiovascular disease: a population-based cohort study

  Total population (n = 408) NFG (n = 253) IFG- ADA (n = 118) NDM(n = 37) P-Value Statistics b
Continuous variables, mean (SD)
 Age (years) 60.6 (10.5) 60.0 (10.9) 61.3 (10.2) 62.8 (8.7) 0.22 1.51
 BMI (kg/m2) 28.2 (4.7) 27.6 (4.6) 29.0 (4.8) 29.2 (4.8) 0.009 4.82
 WC (cm) 97.1 (10.5) 95.6 (10.6) 99.2 (9.8) 100.7 (9.6) 0.001 7.54
 SBP (mmHg) 130.7 (21.2) 128. 4 (20.3) 132.8 (20.7) 139.2 (25.6) 0.006 5.22
 DBP (mmHg) 78.4 (11.8) 78.2(12.2) 78.1 (11.4) 80.2 (9.6) 0.62 0.48
 HR (beats/minute) 76.7 (11.9) 75.7(12.0) 78.3 (12.1) 78.7 (9.9) 0.08 2.49
 FPG (mmol/L) 5.6 (1.4) 5.0(0.4) 6.1 (0.4) 9.1 (2.1)  < 0.001 555.01
 2 h-PCPG (mmol/L) 8.2 (4.3) 6.4(1.8) 8.9 (2.6) 18.2 (5.8)  < 0.001 323.8
 TC (mmol/L) 5.4 (1.1) 5.3 (1.1) 5.4(1.0) 5.8 (1.4) 0.04 3.25
 HDL-C (mmol/L) 0.98(0.2) 0.98(0.2) 0.97(0.3) 0.94 (0.3) 0.69 0.37
 Triglycerides (mmol/L) a 1.85(1.24) 1.8(1.2) 1.8(1.3) 2.4 (1.3) 0.04 4.23
Categorical variables, n (%)
 Gender (men) 238(58.3) 150(59.3) 64(54.2) 24(64.9) 0.47 1.56
 Family history of CVD 62(15.2) 39(15.4) 19(16.1) 4(10.8) 0.79 0.51
 Current smoking 69(16.9) 42(16.6) 20(16.9) 7(18.9) 0.94 0.12
 Low physical activity 174(42.6) 114(45.1) 53(44.9) 7(18.9) 0.007 9.37
 Hypertension 218(53.4) 131(51.8) 66(55.9) 21(56.8) 0.69 0.74
 Hypercholesterolemia 245(60.0) 149(58.9) 73(61.9) 23(62.2) 0.86 0.37
Medications
 Anti-hypertensive medication 133(32.6) 83(32.8) 37(31.4) 13(35.1) 0.88 0.20
 Lipid-lowering medication 45(11.0) 27(10.7) 13(11.0) 5(13.5) 0.83 0.27
 Aspirin use 198(48.5) 129(51.0) 49(41.5) 20(54.1) 0.17 3.38
  1. Values are expressed as mean (SD) or median (interquartile range) for continuous variables and n (%) for categorical variables
  2. Missing values were imputed with multiple imputation. NFG normal fasting glucose, IFG impaired fasting glucose, NDM newly diagnosed diabetes, ADA American Diabetes Association, BMI body mass index, WC waist circumference, SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, FPG fasting plasma glucose, 2 h-PCPG 2 h post challenge plasma glucose, TC total cholesterol, HDL-C High density lipoprotein-cholesterol, CVD cardiovascular disease
  3. aMedian and interquartile range (IQR)
  4. bANOVA F statistics for continues variables and Pearson Chi-square or Fisher exact value for categorical variables. For Triglycerides Kruskal Wallis test was reported